Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
2024 · Blood Cancer Journal · 32 citations
https://doi.org/10.1038/s41408-024-01043-5
B
Bruno Almeida Costa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
995
Citations
16
h-index
23
i10-index
Bruno Almeida Costa is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & CAR-T cell therapy research & Protein Degradation and Inhibitors. The author has an h-index of 16, co-authored 59 publications.
ORCID: 0000-0002-1816-4498Papers by this author
worksPrognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
2024 · Blood Cancer Journal · 26 citations
https://doi.org/10.1038/s41408-024-01048-0
Male-to-Female Gender-Affirming Surgery Using Nile Tilapia Fish Skin as a Biocompatible Graft
2020 · Journal of Minimally Invasive Gynecology · 21 citations
https://doi.org/10.1016/j.jmig.2020.02.017
Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature
2022 · Hematology Transfusion and Cell Therapy · 16 citations
https://doi.org/10.1016/j.htct.2021.11.015
Advancements in bispecific antibodies for multiple myeloma: What's new and what lies ahead
2024 · Seminars in Hematology · 3 citations
https://doi.org/10.1053/j.seminhematol.2024.12.001
Methylphenidate for Depression in Advanced Cancer: Exploratory Meta-Analysis of Randomized Trials
2025 · Journal of Pain and Symptom Management · 1 citations
https://doi.org/10.1016/j.jpainsymman.2025.11.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat